share_log
Moomoo 24/7 ·  Apr 8 08:05
Corcept Completes Enrollment In Pivotal Phase 3 Rosella Trial Of Relacorilant In Patients With Platinum-Resistant Ovarian Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment